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provides temporary circulatory support for patients in refractory cardiogenic shock
(RCS). There is a paucity of data assessing the effects pVAD therapy has on the
hemodynamics and left ventricular (LV) function among patients with RCS. We
assessed whether TandemHeart implantation confers favorable hemodynamic, LV
systolic and LV diastolic functional improvements for patients in RCS.
Methods: Complete clinical data, baseline, hemodynamic and echocardiographic data
were available and reviewed on 18 patients who received TandemHeart for RCS
therapy.
Results: Average duration of support was 5.21 days and the average INTERMACS
score was 1.65. Baseline and mean time for pre and post-implantation assessment by
echocardiography was 1.16 ± 1.42 and 2.5 ± 1.5 days, respectively. Survival rates at
30 days and 9 months were 53% and 44%, respectively. Significant improvements in
hemodynamic and LV systolic function parameters were noted following device
implantation (Table 1). Significant improvements in LV diastolic function included a
decrease in left atrial volume (33.5 ± 13.1 ml/cm2 to 29.68 ± 10.64 ml/cm2 p=0.05)
and decrease in MR (EROA; 0.27 ± 0.08 cm2 to 0.21 ± 0.07 cm2 p=0.008) (Table 1).
Conclusion: TandemHeart confers immediate improvements in the hemodynamics of
patients in RCS as assessed by invasive monitoring. Echocardiographic assessment
confirms that the implantation of TandemHeart provides immediate, hemodynamic
pressure unloading of the LV and improves LV systolic and diastolic function.
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Background: Recent improvement in the care of patient with myocardial infarction
should lead to better outcome. The goal of this study was to evaluate the incidence of
cardiogenic shock occurring in the setting of ST elevation myocardial infarction
(STEMI) in the United state.
Methods: The Nationwide Inpatient Sample (NIS) database was utilized to calculate
the age-adjusted incident rate of cardiogenic shock from 1996 to 2006 based on ICD-
9 coding in the setting of STEMI.
Results: A total population of 52,784,917 patients were available between 1996-2006.
We found that the incidence of cardiogenic shock in the setting of STEMI has been
declining slowly over last 10 years. The age-adjusted rate for cardiogenic shock was
4.3 per 100,000 in 1996 which remained steady with an incidence of 3.1 per 100.000
in 2006 (p<0.01). This decline was persistent across different race or gender.
Conclusion: Advancement in the treatment of acute STEMI has lead to gradual
reduction in the incidence of STEMI related cardiogenic shock irrespective of
ethnicities or gender.
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Background: Stress-induced cardiomyopathy (SIC) is a novel syndrome with a
substantial morbidity and mortality rate. It has become an important differential
diagnosis in patients with acute chest pain and the diagnosis is most frequently made
by the interventional cardiologist in the cath lab. The characteristic hallmark of SIC is
a development of extensive but reversible left ventricular dysfunction which may cause
fulminant heart failure, cardiogenic shock and literally heart rupture leading to death.
In spite of the rapidly increasing number of patients, a lot of elementary facts are
unknown in regard to epidemiology, pathophysiology, prognosis and optimal treatment.
Substantial evidence has been accumulated in the literature during the last couple of
years that renders the SIC diagnostic criteria proposed from Mayo Clinic obsolete.
Methods: Based on the systematic observations from the large cohort of SIC patients
(n=200) from Gothenburg area in Western Sweden we offer a new set of clinical criteria
which we believe better defines the SIC syndrome.
Results: We propose the folowing criteria: 1) Transient hypokinesis, akinesis, or
dyskinesis in the left ventricular segments and frequently, but not always, a stressful
trigger (psychical or physical). 2) The absence of other pathological conditions (e.g.
ischemia, myocarditis, toxic damage, tachycardia, etc.) that may more credibly explain
the regional dysfunction. 3) No elevation or modest elevation in cardiac troponin (i.e.
disparity between the troponin level and the amount of the dysfunctional myocardium
present).
Conclusion: We estimate that as many as ~1000-1500 patients annually develop the
advanced stage of SIC in our country. It is plausible to assume that the true incidence
of SIC is generally much higher if we accept the fact that subclinical and milder forms
of SIC in the population do not come to medical attention and that SIC is often
mistaken for an acute coronary syndrome. SIC may therefore be the most common
form of non-ischemic cardiomyopathy in Sweden and elsewhere.Interventional
cardiologists is an important “first-line” link for the correct and timely diagnosis as
well as for the appropriate therapeutic measures in the care of SIC pts.
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